Perinatal psychiatric episodes: a population-based study on treatment incidence and prevalence by Munk-Olsen, et al.
OPEN
ORIGINAL ARTICLE
Perinatal psychiatric episodes: a population-based study on
treatment incidence and prevalence
T Munk-Olsen1,2, ML Maegbaek1, BM Johannsen1, X Liu1, LM Howard3, A di Florio4,5, V Bergink1,6 and S Meltzer-Brody7
Perinatal psychiatric episodes comprise various disorders and symptom severity, which are diagnosed and treated in multiple
treatment settings. To date, no studies have quantified the incidence and prevalence of perinatal psychiatric episodes treated in
primary and secondary care, which we aimed to do in the present study. We designed a descriptive prospective study and included
information from Danish population registers to study first-time ever and recurrent psychiatric episodes during the perinatal period,
including treatment at psychiatric facilities and general practitioners (GPs). This was done for all women who had records of one or
more singleton births from 1998 until 2012. In total, we had information on 822 439 children born to 491 242 unique mothers.
Results showed first-time psychiatric episodes treated at inpatient facilities were rare during pregnancy, but increased significantly
shortly following childbirth (0.02 vs 0.25 per 1000 births). In comparison, first-time psychiatric episodes treated at outpatient
facilities were more common, and showed little variation across pregnancy and postpartum. For every single birth resulting in
postpartum episodes treated at inpatient psychiatric facilities, 2.5 births were followed by an episode treated at outpatient
psychiatric facility and 12 births by GP-provided pharmacological treatment. We interpret our results the following way: treated
severe and moderate psychiatric disorders have different risk patterns in relation to pregnancy and childbirth, which suggests
differences in the underlying etiology. We further speculate varying treatment incidence and prevalence in pregnancy vs
postpartum may indicate that the current Diagnostic and Statistical Manual of Mental Disorders-5 peripartum specifier not
adequately describes at-risk periods across moderate and severe perinatal psychiatric episodes.
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INTRODUCTION
Psychiatric episodes during pregnancy and following childbirth
are complex, as the well-being of both the mother and infant must
be considered in all treatment decisions. There is general
consensus that childbirth triggers new postpartum episodes that
can be on a spectrum of mild-to-severe presentation. The severe
episodes affect 1–2 per 1000 new mothers,1–3 and have been
described and quantified in a range of diverse studies using
different data sources and study designs, for example, refs 1,2,4–6.
Episodes requiring psychiatric hospitalization and specialist
treatment in secondary and tertiary health-care systems are
thought to be on the severe end of the spectrum. They are often
characterized by severe depression with suicidal ideation,7 or as
postpartum psychosis that has been closely associated with
bipolar affective disorders,8 although it does not have a specific
diagnoses.9,10 Adding to this, a proportion of more moderate
postpartum psychiatric episodes will be treated in primary care
with prescription drugs. Although the threshold for using
pharmacological therapy is different in the perinatal period due
to concerns about possible risks to the fetus and breastfeeding
infant, antidepressants are used as one treatment option for
perinatal depression, particularly non-psychotic moderate-to-
severe depression.11 Antidepressant use in the perinatal period
has increased over time,12,13 as it has for depression outside the
perinatal period. Furthermore, the prevalence of antidepressant
use in pregnancy varies significantly between countries and across
studies: 3% in Denmark14 and 13% in the United States,15 overall
challenging direct comparisons across time periods and between
studies. Adding to this, evidence suggests that some perinatal
psychiatric episodes will be unnoticed and consequently
untreated,16–18 with one recent study highlighting that pharma-
cological treatment is less likely to be prescribed in perinatal
illnesses compared with other time points.19
Together, postpartum psychiatric episodes comprise a range of
different disorders and symptom severity,11,20 which subsequently
are diagnosed and treated in a range of treatment settings. This
poses a significant challenge to the investigation of incidence of
postpartum psychiatric episodes, as the data from various settings
are needed. An additional challenge is that the most available
data in the field does not differentiate between first-time episodes
vs recurrent episodes, which in epidemiological terms can be
described as mixing incident and prevalent case groups. Finally,
past diagnostic specifiers in the Diagnostic and Statistical Manual
of Mental Disorders (DSM) and International Classification of
Diseases (ICD) diagnostic systems vary in terms of defining
postpartum onset ranging from 4 to 6 weeks postpartum,21,22 with
the recent shift from DSM-4 to DSM-5 to also include psychiatric
episodes in pregnancy as well as postpartum episodes.21,23
To date, no studies have quantified the proportion of
psychiatric episodes occurring during pregnancy and postpartum
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treated in a range of health-care settings including inpatient
psychiatry, outpatient psychiatry and outpatient primary care.
Similarly, no studies have jointly compared number of mothers
with first-time episodes to recurrent episodes to make a
comprehensive overview. Therefore, in the present study, we
aimed to conduct a descriptive summary of first-time and
recurrent psychiatric episodes across diagnostic categories in
pregnancy and the postpartum period using various Danish
population registers. We examined psychiatric disorders around
childbirth within Danish health-care systems, including psychiatric
inpatient and outpatient health-care treatment facilities, and
prescriptions for psychotropic medication provided by family
doctors in primary care as a proxy measure for moderate perinatal
psychiatric episodes.
MATERIALS AND METHODS
Study design
The present study was designed as a descriptive prospective study based
on the information from different Danish population registers. In designing
this study, we aimed to present an overview of perinatal (pregnancy and
postpartum) psychiatric episodes measured as incidence and prevalence
of the combined records of women treated in various primary and
secondary/tertiary health-care settings measured as either first-time or
recurrent contacts. This was done for women born 1955 or later, who had
records of one or more singleton births from 1 January 1998 until 31
December 2012.
Data sources
Three different population registers provided information for the present
study, and the information was linked through the CPR number, which is a
personal identification number assigned to all citizens in the country.24
Women were identified through the Civil Registration System, which was
initiated in 1968 and holds updated information on vital status (dates of
birth, migration and death) and links to legal family members.24 Further
data sources were: The Psychiatric Central Register, with available
information on inpatient treatment since 1969 and outpatient treatment
since 1995;25 and The prescription registry with available information on
general practitioner (GP) provided prescriptions since 1995.26
Identification of women, births and perinatal psychiatric episodes
We identified 1 908 494 women born in Denmark from 1 January 1955 and
onwards, and considered only those with one or more singleton childbirths
later than 1 January 1998. In total, we had 822 439 children born to
491 242 unique mothers. When looking at first-time and recurrent records,
we considered each month, beginning at 9 months before birth until
12 months after birth with 1 month being defined as 30 days. By restricting
to childbirths after 1 January 1998, we ensured a washout period of at least
2 years and 3 months where women were medication free, which was
done to ensure correct classification of first-time prescriptions. Among the
identified women, we examined each individual pregnancy and childbirth,
and for women with multiple children, we obtained information regarding
mental health for each of the recorded individual childbirths. For all births,
we identified a pregnancy and postpartum period, defined as the period of
time from 9 months before to date of birth (pregnancy) and from date of
birth through 12 months after birth (postpartum).
In Denmark, all diagnoses are recorded using the ICD-10 classification
system since 1994, and before 1994, the ICD-8 classification system was
used.22,27 Perinatal psychiatric episodes were defined in one of the
following ways: (1) any type of recorded and/or treated psychiatric
diagnoses at psychiatric treatment facilities (both inpatient and outpatient
settings) or (2) were prescribed either antidepressants or antipsychotics.
More precisely, the treated psychiatric episodes were defined as either any
type of F chapter ICD-10 code: mental and behavioral disorders at
inpatient or outpatient treatment psychiatric treatment sites in Denmark.
Similarly, we used equivalent ICD-8 codes: 290–315 before 1994, to identify
whether ICD-10 contacts were incident or prevalent. Also, we identified
psychiatric episodes treated with antidepressants or antipsychotics, using
the following Anatomical Therapeutical Chemical classification codes: N03-
N07, which covered all prescriptions from GPs treating women in primary
care during the defined pregnancy and postpartum period. Note that
prescription data were used as a diagnostic proxy measure for moderate
perinatal psychiatric episodes identified and treated in primary care
settings by GPs.
For our study, we defined three different pregnancy and postpartum
psychiatric episode groups ranging in disease severity, which were
identified and treated at three different treatment settings:
1. Severe perinatal psychiatric episodes. Treatment setting: psychiatric
inpatient treatment facility (secondary and tertiary care). Definition: all
recorded F-diagnoses (ICD-10: mental and behavioral disorders).
2. Moderate perinatal psychiatric episodes. Treatment setting: psychiatric
outpatient treatment facility (secondary care). Definition: all recorded
F-diagnoses (ICD-10: mental and behavioral disorders).
3. Moderate perinatal psychiatric episodes. Treatment setting: Medical
doctor/GP clinics (primary care). Definition: pharmacological treatment/
prescriptions: N03-N07 (Anatomical Therapeutical Chemical codes).
The above-mentioned categorizations were made to capture perinatal
psychiatric episodes, which range in severity and subsequently will be
treated at different treatment sites. The episodes were therefore named
moderate and severe for clarification, with the distinction being based on
the information regarding treatment sites.
Statistical analyses
The outcome measures for the present study were calculation of incidence
and prevalence of perinatal psychiatric episodes in the three different
treatment settings described above. This was done to provide information
about how many new cases of psychiatric episodes including all recorded
psychiatric diagnoses were recorded around pregnancy and postpartum
(incidence), compared with measuring how widespread pregnancy and
postpartum psychiatric episodes are (prevalence). First-time cases (inci-
dence) were counted as the first-ever contact to the specific treatment
setting with the specific treatment or diagnoses within the time period
from 9 months before through 12 months after birth. The incidence was
then calculated for each birth as the number of incident cases for each
month divided by the total number of births. Note that our incidence
definition meant that we identified first-ever episodes, and that the
women also had no records of treatment before conception (outside the
perinatal period). To ensure that our calculation of first-time treatment was
indeed incident treatment, we introduced a washout period excluding all
women with records of treated psychiatric episodes at the different
treatment settings before 1 January 1998. As the individual registers/data
sources were established at different time points, this introduced varying
washout period from 2 years (prescription data) up425 years (psychiatric
inpatient treatment data).
Recurrent (prevalent) contacts were defined as all registered contacts in
any of the three treatment settings from 9 months before through
12 months after birth, where contacts were counted on a monthly basis.
This meant that for each month, we considered whether there was any
record of treatment, with recurrent cases only counted once for each
month. Note that our prevalence definition meant that women could have
had records of treated psychiatric episodes both in a previous perinatal
period and/or outside a perinatal period. For each birth, the prevalence
was calculated as the number of recurrent cases divided by the total
number of births.
In addition, we calculated incidence proportion and prevalence of
treated postpartum psychiatric episodes jointly for the first 3 months
postpartum to present an overall estimate for the first-time period
following childbirth, which is particularly associated with both first onset
and recurrence of psychiatric episodes.1
As a means for further explanation, consider the following example:
woman A experiences severe depression 3 months postpartum, which is
the first-ever episode of any recorded psychiatric disorder. She is admitted
and treated at a psychiatric inpatient facility. For the calculated incidences,
she is then recorded with her first-time episode 3 months after childbirth
and contributes to the calculated incidence for this particular month. If
woman A is readmitted to psychiatric treatment 9 months postpartum, she
will only be included in the calculation of incidence in the third month
postpartum, whereas she will contribute information in the calculation of
prevalence at both 3 and 9 months postpartum.
For information regarding the code used to generate the results, please
contact the first author.
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RESULTS
Based on the data covering 822 439 children born to 491 242
mothers, we studied the incidence and prevalence of postpartum
psychiatric episodes in various treatment settings.
Inpatient psychiatric treatment facilities
First-time and recurrent psychiatric episodes treated at psychiatric
inpatient facilities were most common within the first month
following childbirth, 0.25 and 0.40 per 1000 births (Figure 1). At
any time during the observation period from 9 months before
birth through 12 months following the lowest observed incidence
and prevalence was the last month before childbirth, 0.02 and
0.06 per 1000 births (Figure 1).
Outpatient psychiatric treatment facilities
Between 31 and 60 days postpartum, the highest incidence of
first-time psychiatric episodes treated at outpatient facilities was
observed (0.60 per 1000 births, Figure 2). Both the incidence and
prevalence of treated psychiatric episodes at outpatient clinics
showed little variation when comparing the pregnancy period
with the postpartum period (Figure 2).
Primary care provided pharmacological treatment
First-time prescriptions with antidepressants and antipsychotics
were most common within the first month postpartum (3.81 per
1000 births; Figure 3). In comparison, there was also a significant
increase in prevalent prescriptions postpartum compared with the
pregnancy period (14.74 per 1000 births; Figure 3).
Incidence proportion and prevalence of perinatal psychiatric
episodes
Overall measures of incidence proportion and prevalence
0–3 months postpartum are shown in Table 1. The incidence
proportion 0–3 months postpartum for psychiatric episodes
treated at inpatient psychiatric facilities was 0.64 per 1000 births.
In comparison, the incidence proportion was 7.72 per 1000 births
for psychiatric episodes treated in primary care with antidepres-
sants and antipsychotics. This could be interpreted the following
way: for every single birth resulting in postpartum episodes
treated at psychiatric inpatient treatment facilities, 12 births are
followed by a psychiatric episode treated with GP prescribed
antidepressants or antipsychotics (7.72/0.64 = 12.06). For every
birth resulting in postpartum episodes treated at inpatient
treatment facilities, 2.5 are followed by a psychiatric episode
treated at outpatient psychiatric treatment facilities (1.63-
/0.64 = 2.55). Adding to this, for every postpartum psychiatric
episode treated in outpatient treatment facilities 4.7 are treated
with antidepressants (7.72/1.63 = 4.74).
DISCUSSION
Childbirth as a trigger for psychiatric episodes
Our data confirmed that childbirth is a potent and highly significant
trigger of severe psychiatric episodes. We identified a rapid increase
of particularly inpatient-treated episodes shortly following child-
birth, and the first postpartum months were associated with the
highest risks of both first-time and recurrent episodes. More
precisely, we found that in 0.64 per 1000 births, mothers
experienced new psychiatric episodes necessitating treatment at
inpatient psychiatric treatment facilities 0–3 months postpartum.
This estimate is lower than previously reported incidences of
postpartum psychosis/severe postpartum psychiatric episodes, 1
per 1000.1,2 We speculate that the reasons for this difference reflect
changes across calendar time, as the number of available inpatient
beds has decreased during the past decades,28 and possibly a
subsequent shift toward treatment in outpatient clinic settings.
Applying an observation period of 3 months postpartum, we
found that for every 1000 births the following numbers of
psychiatric first-time episodes were treated: 0.64 inpatient
psychiatric treatment, 1.63 outpatient psychiatric treatment and
7.72 primary care-treated moderate episodes treated with
prescriptions of antidepressants/antipsychotics. This demonstrates
that the majority of postpartum episodes are treated in primary
care settings, but these numbers also reflect a difference in
severity of the disorders, with inpatient admissions representing
the most severe end of the spectrum.
The newest version of the DSM classification system introduced
a peripartum specifier for disease onset both during pregnancy
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Figure 1. First-time and recurrent psychiatric episodes in the perinatal period treated at psychiatric inpatient facilities. Information on
admissions to psychiatric treatment facilities came from the Psychiatric Central Register, with data available since 1969. Y axis: permille (out of
1000)=per 1000 births.
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Figure 2. First-time and recurrent psychiatric episodes in the perinatal period treated at psychiatric outpatient facilities. Information on
outpatient treatment at psychiatric treatment facilities came from the Psychiatric Central Register, with data available since 1995. Y axis:
permille (out of 1000)=per 1000 births.
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Figure 3. First-time and recurrent GP-provided prescriptions with antidepressants or antipsychotics in the perinatal period. Information on GP-
provided prescriptions came from the Danish National Prescription Registry, with data available since 1995. Y axis: permille (out of 1000)=per
1000 births. GP, general practitioner.
Table 1. Incidence proportion and prevalence 0–3 months postpartum for psychiatric episodes treated across the Danish health-care system
Treated postpartum psychiatric episodes Incidence proportion 0–3 months postpartum
(per 1000 births)
Prevalence 0–3 months postpartum
(per 1000 births)
Psychiatric inpatient treatment facility 0.64 0.94
Psychiatric outpatient treatment facility 1.63 2.83
GP-provided prescriptions (antidepressants/antipsychotics) 7.72 29.35
Abbreviation: GP, general practitioner. 0–3 months= 0–90 days postpartum. Incidence proportion 0–3 months postpartum: defined as first-ever contacts=no
previous contacts both in pregnancy and before conception. Prevalence 0–3 months postpartum: If a woman, for example, had records of two prescriptions
within 0–90 days postpartum, she was calculated twice for this measure. Note women can have had a previous record of treated psychiatric episode both
perinatally and/or outside the perinatal period.
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and postpartum,23 which is different from the previous definition
for a specifier solely related to the postpartum period.21 The
register data used for the present study are administrative and
measures contacts with the health-care system, but not the onset
of specific illness. Consequently, some women may have had the
onset within the time put out by the DSM specifier. However,
when observing our findings, the peripartum specifier may be a
useful definition for the patterns of treatment especially in
outpatient clinics (Figure 2), as we here did not observe wide
variations between pregnancy and postpartum for the more
moderate episodes. In comparison, when we examined data
covering more severe episodes that required inpatient psychiatric
treatment, the variation between the pregnancy period and
postpartum was vast with a very low incidence in pregnancy and a
clear peak in incidence shortly following childbirth (Figure 1). This
may suggest that a peripartum specifier as used in the DSM
system is not the most suitable definition for disorders in the most
severe end of the spectrum, and we further hypothesize that these
episodes could have different underlying etiologies than the less
severe episodes. However, for other purposes such as service
planning a peripartum specifier could be beneficial, and hence it is
important to consider how a specifier is useful and which time
period the definition should include.
Childbirth triggers first-ever severe episodes that are treated at
inpatient psychiatric facilities (Figure 1). This is a particularly
concerning observation, as we at present are not able to predict
which women will become ill postpartum.29,30 However, the
majority of the treated severe postpartum episodes are recurrent
episodes (Figure 1), meaning that the majority of women with
severe episodes following childbirth are patients with previous
records of treated psychiatric disorders outside the postpartum
period. For these female patients, treatment and prevention plans
should be available and initiated, especially if the individual
women have histories of bipolar disorders or postpartum
psychosis.31 Such plans could include medication prophylaxis,
birth plan, intervention strategies from earliest signs of prodromal
symptoms, neonatal medical evaluation, breastfeeding prefer-
ences and strategies for adequate sleep, maintenance of stable
circadian rhythm, stress reduction, and support of maternal–
newborn bonding.31
Treatment to pregnant and postpartum women
Pharmacological treatment to pregnant and postpartum women
has received a lot of attention, with concerns about the health of
baby vs consequences of untreated mental disorders in the
mothers posing the biggest dilemma.32,33 Prescription patterns in
the present study showed lower rates of use of antidepressants
and antipsychotics during pregnancy and an increase following
childbirth, but mainly for first-time prescriptions. This could
indicate that Danish GPs are reluctant to prescribe medication
to pregnant women due to concerns about teratogenicity and
may choose non-pharmacologic treatment, including psychologi-
cal intervention.12,34 It is also possible that any increase in
recorded prescriptions postpartum may not solely reflect a
worsening of depressive symptoms, but also serves as a marker
of treatment being postponed to after childbirth. This explanation
is based on the observation that the rate of psychiatric medication
prescription around time of conception is similar to the levels
postpartum, especially for the recurrent cases. If this explanation is
correct, any interpretation of the onset and recurrence of
depressive symptoms during pregnancy is challenged. Impor-
tantly, there is no evidence that pregnancy is directly protective
for the new occurrence or recurrence of psychiatric episodes. In
our data, the decrease in prescribing of psychiatric medication
during pregnancy was not compensated by an increase in
outpatient treatments, which could include both pharmacological
and non-pharmacological treatment options. Consequently, these
findings suggest that many women with psychiatric episodes
remain untreated during pregnancy. This is highly worrying, as
untreated depression or other psychiatric episodes is associated
with increased suicide risks in new mothers.19
In conclusion, our findings support and expand upon the
previous work documenting that the postpartum period is a high-
risk period for psychiatric episodes. In particular, childbirth
especially triggers first-time severe psychiatric episodes requiring
inpatient treatment and these episodes may require a distinct
classification within diagnostic systems. In contrast, there is limited
evidence for an increase in moderate psychiatric episodes
postpartum compared with the pregnancy period, and for this
category, the DSM-5 specifier ‘with perinatal onset’ might
adequately cover the at-risk period. Childbirth also triggers
recurrence of severe psychiatric episodes, for which intervention
and treatment plans should be prepared. Overall, our results
suggest that there may be differences in the underlying etiology
behind postpartum psychiatric episodes as we observed differ-
ences in the observed treatment incidence and prevalence for
moderate versus severe episodes, as well as differences in risks
during pregnancy vs postpartum.
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